Company intelligence / Profile preview

SmartNuclide

Suzhou, Jiangsu, Chinasmartnucl.com ↗
Ownership
Private
Employees
~100
Development stage
Other
01

Overview

SmartNuclide has commercialized its recombinant human thyroid stimulating hormone product in China and is advancing multiple innovative radioactive diagnostic and therapeutic products through clinical development. Its lead radioactive diagnostic agents are in early clinical trials, including a PD-L1-targeted nanobody tracer that has received IND approval from the US FDA. The company’s pipeline includes more than ten programs spanning preclinical to clinical stages, primarily focused on oncology indications such as solid tumors and differentiated thyroid carcinoma.

Therapeutic areas
Oncology
Modalities
Recombinant proteinMonoclonal antibody fragmentRadiopharmaceuticalRadioactive imaging agentRadioactive therapeutic agent
Industry
Biotech
02

Drug pipeline

18 assets

SNA001

3

17 more assets in the full pipeline.

03

Partnerships

Collaborations with domestic and international universities, research institutes, medical institutions

Beyond the preview

Go deeper on SmartNuclide.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SmartNuclide.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call